Who owns Infinity Pharmaceuticals?

Key details on Infinity Pharmaceuticals (Ticker: INFI)

Who owns Infinity Pharmaceuticals?

Is INFI a good stock to own? Find out who bought Infinity Pharmaceuticals, who sold Infinity Pharmaceuticals (INFI) stock, and who holds a large position in Infinity Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
OrbiMed Advisors 4.74M $63.57M Sept. 30, 2014
GOLDMAN SACHS 4.00M $47.58M March 31, 2014
Deerfield Management Company 3.88M $52.11M Sept. 30, 2014
S.A.C. Capital Advisors 3.41M $40.56M March 31, 2014
FMR 3.37M $45.28M Sept. 30, 2014
Perceptive Advisors 3.25M $157.49M March 31, 2013
Quogue Capital 2.91M $101.68M Dec. 31, 2012
Vanguard 2.72M $36.58M Sept. 30, 2014
BB Biotech AG 2.32M $31.14M Sept. 30, 2014
Point72 Asset Management 2.20M $29.52M Sept. 30, 2014
BVF 2.18M $19.31M Dec. 31, 2011
BlackRock Fund Advisors 2.15M $28.85M Sept. 30, 2014
Wellington Management Company 1.79M $22.78M June 30, 2014
STATE STREET CORPORATION 1.73M $23.20M Sept. 30, 2014
Broadfin Capital 1.44M $425.27M June 30, 2014
BlackRock Institutional Trust Company, N.A. 1.32M $17.69M Sept. 30, 2014
Consonance Capital 1.26M $15.01M March 31, 2014
Millennium Management 1.21M $16.22M Sept. 30, 2014
BlackRock Advisors 1.17M $20.36M Sept. 30, 2013
Dr. Jeffrey R. Jay, M.D. 1.10M $14.76M Sept. 30, 2014
Visium Asset Management 951852 $13.15M Dec. 31, 2013
HealthCor Management 923600 $11.77M June 30, 2014
SUSQUEHANNA INTERNATIONAL 822165 $11.03M Sept. 30, 2014
Oxford Asset Management 811331 $13.18M June 30, 2013
Ameriprise Financial 777357 $9.24M March 31, 2014
QVT Financial 720947 $9.96M Dec. 31, 2013
Adage Capital Partners GP 700000 $8.32M March 31, 2014
Barclays 692800 $16.29M Sept. 30, 2012
Deutsche Bank Aktiengesellschaft 681160 $9.41M Dec. 31, 2013
Hambrecht & Quist Capital Management 680746 $8.67M June 30, 2014
NORTHERN TRUST 666348 $9.21M Dec. 31, 2013
D. E. Shaw & Co 632753 $10.28M June 30, 2013
Baker Bros. Advisors 624050 $7.95M June 30, 2014
PointState Capital 623108 $14.65M Sept. 30, 2012
T. Rowe Price Associates 622520 $7.93M June 30, 2014

Who sold Infinity Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wells Fargo & Company Sept. 30, 2011 868259 $5.79M
NEA Management Company June 30, 2011 876492 $7.24M
First Eagle Investment Management June 30, 2011 626122 $5.17M